Question 1

How many shares of TNGX does JACOBS LEVY EQUITY MANAGEMENT, INC own?

Accepted Answer

JACOBS LEVY EQUITY MANAGEMENT, INC previously held 0 shares of TNGX (Tango Therapeutics, Inc.) before exiting the position in 2025-Q3.

Question 2

What is JACOBS LEVY EQUITY MANAGEMENT, INC's TNGX position worth?

Accepted Answer

JACOBS LEVY EQUITY MANAGEMENT, INC's TNGX position was last reported at $0 in 2025-Q3 before the exit.

Question 3

Is JACOBS LEVY EQUITY MANAGEMENT, INC buying or selling TNGX?

Accepted Answer

In 2025-Q3, JACOBS LEVY EQUITY MANAGEMENT, INC exited their TNGX position entirely (-100.0% change in shares).

Question 4

When did JACOBS LEVY EQUITY MANAGEMENT, INC first buy TNGX?

Accepted Answer

Based on available 13F filings, JACOBS LEVY EQUITY MANAGEMENT, INC first reported a position in TNGX in 2024-Q4. They have held the position across 12 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2025-Q3 Latest	Exited	0	-100.0%	$0	0.0%	$8.44	0
2025-Q2	Decreased	218,779	-70.3%	$1.1M	0.0%	$5.01	0
2025-Q1	Increased	737,955	+42.6%	$1M	0.0%	$1.47	34
2024-Q4	New	517,426	—	$1.6M	0.0%	$3.10	35